Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis
Keywords: Therapy; TLR-9; Toll-like receptor-9; Ulcerative colitis;